Navigation Links
Dr. Paul Karila Appointed Head of Discovery Services at Cellectricon AB
Date:6/7/2012

GOTHENBURG, Sweden, June 7, 2012 /PRNewswire/ --

Cellectricon is pleased to announce the appointment of Paul Karila as the company's Head of Discovery Services. Dr. Karila brings a solid and highly impressive neuroscience discovery track record to Cellectricon, important for the company's expansion in bringing state-of-the-art discovery services to market. Paul has extensive experience of the drug discovery industry and has held several management positions at AstraZeneca.

The Company's Discovery Services will be based on the proprietary Cellaxess® Elektra platform for automated cellular electric field manipulation enabling novel screening applications in the CNS and Cardiovascular therapeutic fields.

Cellectricon's CEO David Burns said: "Cellectricon is delighted with the appointment of Dr. Karila. We are looking forward to working with Paul's experience and direction to broaden our cell-based CNS and Cardiovascular Discovery Services using the Company's strong IP and technology position to accelerate discovery through collaborations with our pharmaceutical partners".

Dr. Karila added:  "Cellectricon has a strong reputation in the discovery industry with equally strong customer validation and well-earned reputation for providing groundbreaking products and services to the pharmaceutical and life science research markets. Working with the strong scientific team, I will focus on further developing and providing outstanding cell-based discovery services to our customers to accelerate their drug discovery and biological research. "

Cellectricon is a leading provider of advanced cell-based screening technologies and services to accelerate drug discovery and cell-based assay research. Our proprietary technologies include leading systems for high resolution ion-channel screening and cell engineering. Developed in close collaboration with leaders in the pharmaceutical industry and esteemed research labs, the Cellaxess® Technology enables scalable field stimulation, compound delivery and transfection for genomic screening of primary cells, neurones and stem cells. The Dynaflow® Technology advances ion channel research and discovery applications.

http://www.cellectricon.com


'/>"/>
SOURCE Cellectricon AB
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Israel Makov Appointed Chairman of Sun Pharma Board
2. New Executive Vice President Commercial Appointed
3. Herb Baer Appointed President of Polar USA
4. Anthony McKeever Appointed as Chief Executive of MedeAnalytics International
5. Samuel J. Sears, Jr. Appointed to BioDelivery Sciences Board of Directors
6. ActiveCare, Inc. Announces a Newly Appointed CEO
7. Nader Naeymi-Rad Appointed CEO of Campbell Alliance
8. David J. Illingworth Appointed to Board of Directors for Varian Medical Systems
9. Nils Bergenhem, PhD - Newly Appointed President and Chief Scientific Officer of Egenix, Inc.
10. New Senior Executives Appointed at Sanofi:
11. Lilly Quality Leader Walsh Appointed to Companys Executive Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 2016  Licenders is bringing their 100% all-natural lice removal service ... Slope at 203 13 th Street was specifically chosen to ... "Our goal is to ease parents, stress and bring ... get children right back to class without skipping a beat. The ... safe for the whole family," Licenders President Adie Horowitz ...
(Date:12/6/2016)... 2016 Diabetes & Obesity Drug Development Pipeline ... disease cluster is currently dominated by therapeutics indicated for ... mellitus (T2DM), and the majority of the pipeline, in ... attributable to these indications. While products indicated for obesity ... are a large number of these products in the ...
(Date:12/6/2016)... -- Human Vaccines Market: Scope and Methodology ... wise analysis of the human vaccines market. Stakeholders ... products, raw material suppliers, vaccine processing companies, and ... The report provides qualitative and quantitative analysis of ... market dynamics, trends, product overview, and country-level market ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... 06, 2016 , ... The International Vaccine Institute (IVI) and ... the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). The collaboration will accelerate MERS-CoV vaccine ... deployment in the event of a future outbreak. , IVI and GeneOne held ...
(Date:12/6/2016)... ... 2016 , ... According to a November 1 article published on ... or not drinking enough water, which can cause bad breath (known medically as halitosis). ... oral hygiene not only helps reduce the possibility of bad breath, but it can ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... for population health management, announces today a strategic relationship with CitiusTech, a ... clinical rules engine that offers advanced Clinical Quality Measures (CQM) computation capabilities ...
(Date:12/6/2016)... ... December 06, 2016 , ... In anticipation for the New Year, ... availability of continuing education courses in 2017, dentists of all levels can continue to ... in January, dentists can attend a variety of continuing education courses each month on ...
(Date:12/6/2016)... ... ... Why does the prevalence of obesity continue to increase worldwide? Some would say ... the cause of obesity in his new book “Body Weight Regulation.” , “Body ... a healthy life. Proietto said understanding the regulation of body weight and the causes ...
Breaking Medicine News(10 mins):